BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 411 filers reported holding BIO-TECHNE CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,064,000 | +26.2% | 17,520 | +18.2% | 1.16% | +19.3% |
| Q3 2021 | $7,181,000 | +9.1% | 14,820 | +1.4% | 0.97% | +8.4% |
| Q2 2021 | $6,582,000 | -20.6% | 14,618 | -32.6% | 0.90% | -23.4% |
| Q1 2021 | $8,286,000 | +4.7% | 21,695 | -12.9% | 1.17% | -4.9% |
| Q4 2020 | $7,913,000 | +25.6% | 24,919 | -2.0% | 1.23% | +3.1% |
| Q3 2020 | $6,299,000 | -4.5% | 25,425 | +1.8% | 1.19% | -13.2% |
| Q2 2020 | $6,593,000 | -11.2% | 24,966 | -36.2% | 1.38% | -17.4% |
| Q1 2020 | $7,423,000 | -35.6% | 39,146 | -25.5% | 1.66% | -12.6% |
| Q4 2019 | $11,531,000 | +11.5% | 52,531 | -0.7% | 1.90% | +3.6% |
| Q3 2019 | $10,346,000 | -20.0% | 52,877 | -14.7% | 1.84% | -16.3% |
| Q2 2019 | $12,930,000 | +3.5% | 62,017 | -1.4% | 2.20% | 0.0% |
| Q1 2019 | $12,494,000 | +65.8% | 62,927 | +20.9% | 2.20% | +39.2% |
| Q4 2018 | $7,534,000 | -7.6% | 52,062 | +30.3% | 1.58% | +18.3% |
| Q3 2018 | $8,156,000 | -17.7% | 39,957 | -40.3% | 1.33% | -20.5% |
| Q2 2018 | $9,906,000 | -14.6% | 66,955 | -12.8% | 1.68% | -23.8% |
| Q1 2018 | $11,593,000 | +7.7% | 76,755 | -7.7% | 2.20% | +8.7% |
| Q4 2017 | $10,769,000 | +44.1% | 83,128 | +34.5% | 2.03% | +35.7% |
| Q3 2017 | $7,473,000 | +60.7% | 61,813 | +56.2% | 1.49% | +41.7% |
| Q2 2017 | $4,650,000 | – | 39,575 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ownership Capital B.V. | 972,263 | $308,742,000 | 4.35% |
| Sandhill Capital Partners LLC | 138,864 | $44,096,000 | 4.03% |
| STONE RUN CAPITAL, LLC | 27,350 | $8,685,000 | 3.45% |
| DF DENT & CO INC | 925,823 | $293,995,000 | 3.42% |
| Brown Capital Management | 1,498,233 | $475,764,000 | 3.29% |
| MAIRS & POWER INC | 848,081 | $269,308,000 | 2.99% |
| Summit Creek Advisors LLC | 64,179 | $20,380,000 | 2.62% |
| GENEVA CAPITAL MANAGEMENT LLC | 402,958 | $127,959,000 | 2.17% |
| Aristotle Atlantic Partners, LLC | 86,993 | $27,625,000 | 2.13% |
| CROWN ADVISORS MANAGEMENT, INC. | 8,000 | $2,540,000 | 1.82% |